Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication
This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer. A total of 1824 H. pylori-infected subjects were enrolled to receive screening end...
Saved in:
Published in | Journal of the Formosan Medical Association Vol. 122; no. 5; pp. 400 - 410 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Elsevier B.V
01.05.2023
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0929-6646 1876-0821 |
DOI | 10.1016/j.jfma.2022.11.008 |
Cover
Loading…
Abstract | This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer.
A total of 1824 H. pylori-infected subjects were enrolled to receive screening endoscopy. Among them, 491 received surveillance endoscopy. The patients were divided into Correa's steps I to VI, from normal to gastric cancer. A group-based trajectory model was used to classify patients as persistent high-risk status or not.
The prevalence rates of positive corpus-predominant gastritis index (CGI) were 20%–40% in all age groups and Correa's steps IV-V increased >35% after 50 years based on screening endoscopy. Successful eradication of H. pylori regressed CGI after the 1st year-and-thereafter (P < 0.05) and decreased Correa's step progression (Relative risk 0.66 [95% CI 0.49–0.89], P = 0.01); however, it did not regress OLGA and OLGIM. Not only in steps IV-V, but also in step III, the patients had a risk of developing gastric cancer (11.13–76.41 and 4.61 per 1000 person-years). Age (Hazard ratio 1.012 [1.003–1.020], P = 0.01), OLGA stages ≥ I (2.127 [1.558–2.903], P < 0.001), and OLGIM stages ≥ I (1.409 [1.119–1.774], P = 0.004) were correlated independently with a persistent high-risk status.
The patients in Correa's steps III-V, but not I-II, were at risk of gastric cancer after H. pylori eradication. Age, OLGA stages ≥ I, and OLGIM stages ≥ I were independent factors correlated to a persistent high-risk of gastric cancer. The data may be useful when scheduling surveillance endoscopy for subjects in each Correa's step (NCT04527055). |
---|---|
AbstractList | Background: This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer. Methods: A total of 1824 H. pylori-infected subjects were enrolled to receive screening endoscopy. Among them, 491 received surveillance endoscopy. The patients were divided into Correa's steps I to VI, from normal to gastric cancer. A group-based trajectory model was used to classify patients as persistent high-risk status or not. Results: The prevalence rates of positive corpus-predominant gastritis index (CGI) were 20%–40% in all age groups and Correa's steps IV-V increased >35% after 50 years based on screening endoscopy. Successful eradication of H. pylori regressed CGI after the 1st year-and-thereafter (P < 0.05) and decreased Correa's step progression (Relative risk 0.66 [95% CI 0.49–0.89], P = 0.01); however, it did not regress OLGA and OLGIM. Not only in steps IV-V, but also in step III, the patients had a risk of developing gastric cancer (11.13–76.41 and 4.61 per 1000 person-years). Age (Hazard ratio 1.012 [1.003–1.020], P = 0.01), OLGA stages ≥ I (2.127 [1.558–2.903], P < 0.001), and OLGIM stages ≥ I (1.409 [1.119–1.774], P = 0.004) were correlated independently with a persistent high-risk status. Conclusion: The patients in Correa's steps III-V, but not I-II, were at risk of gastric cancer after H. pylori eradication. Age, OLGA stages ≥ I, and OLGIM stages ≥ I were independent factors correlated to a persistent high-risk of gastric cancer. The data may be useful when scheduling surveillance endoscopy for subjects in each Correa's step (NCT04527055). This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer. A total of 1824 H. pylori-infected subjects were enrolled to receive screening endoscopy. Among them, 491 received surveillance endoscopy. The patients were divided into Correa's steps I to VI, from normal to gastric cancer. A group-based trajectory model was used to classify patients as persistent high-risk status or not. The prevalence rates of positive corpus-predominant gastritis index (CGI) were 20%-40% in all age groups and Correa's steps IV-V increased >35% after 50 years based on screening endoscopy. Successful eradication of H. pylori regressed CGI after the 1st year-and-thereafter (P < 0.05) and decreased Correa's step progression (Relative risk 0.66 [95% CI 0.49-0.89], P = 0.01); however, it did not regress OLGA and OLGIM. Not only in steps IV-V, but also in step III, the patients had a risk of developing gastric cancer (11.13-76.41 and 4.61 per 1000 person-years). Age (Hazard ratio 1.012 [1.003-1.020], P = 0.01), OLGA stages ≥ I (2.127 [1.558-2.903], P < 0.001), and OLGIM stages ≥ I (1.409 [1.119-1.774], P = 0.004) were correlated independently with a persistent high-risk status. The patients in Correa's steps III-V, but not I-II, were at risk of gastric cancer after H. pylori eradication. Age, OLGA stages ≥ I, and OLGIM stages ≥ I were independent factors correlated to a persistent high-risk of gastric cancer. The data may be useful when scheduling surveillance endoscopy for subjects in each Correa's step (NCT04527055). This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer.BACKGROUNDThis study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the factors correlated with a high-risk of gastric cancer.A total of 1824 H. pylori-infected subjects were enrolled to receive screening endoscopy. Among them, 491 received surveillance endoscopy. The patients were divided into Correa's steps I to VI, from normal to gastric cancer. A group-based trajectory model was used to classify patients as persistent high-risk status or not.METHODSA total of 1824 H. pylori-infected subjects were enrolled to receive screening endoscopy. Among them, 491 received surveillance endoscopy. The patients were divided into Correa's steps I to VI, from normal to gastric cancer. A group-based trajectory model was used to classify patients as persistent high-risk status or not.The prevalence rates of positive corpus-predominant gastritis index (CGI) were 20%-40% in all age groups and Correa's steps IV-V increased >35% after 50 years based on screening endoscopy. Successful eradication of H. pylori regressed CGI after the 1st year-and-thereafter (P < 0.05) and decreased Correa's step progression (Relative risk 0.66 [95% CI 0.49-0.89], P = 0.01); however, it did not regress OLGA and OLGIM. Not only in steps IV-V, but also in step III, the patients had a risk of developing gastric cancer (11.13-76.41 and 4.61 per 1000 person-years). Age (Hazard ratio 1.012 [1.003-1.020], P = 0.01), OLGA stages ≥ I (2.127 [1.558-2.903], P < 0.001), and OLGIM stages ≥ I (1.409 [1.119-1.774], P = 0.004) were correlated independently with a persistent high-risk status.RESULTSThe prevalence rates of positive corpus-predominant gastritis index (CGI) were 20%-40% in all age groups and Correa's steps IV-V increased >35% after 50 years based on screening endoscopy. Successful eradication of H. pylori regressed CGI after the 1st year-and-thereafter (P < 0.05) and decreased Correa's step progression (Relative risk 0.66 [95% CI 0.49-0.89], P = 0.01); however, it did not regress OLGA and OLGIM. Not only in steps IV-V, but also in step III, the patients had a risk of developing gastric cancer (11.13-76.41 and 4.61 per 1000 person-years). Age (Hazard ratio 1.012 [1.003-1.020], P = 0.01), OLGA stages ≥ I (2.127 [1.558-2.903], P < 0.001), and OLGIM stages ≥ I (1.409 [1.119-1.774], P = 0.004) were correlated independently with a persistent high-risk status.The patients in Correa's steps III-V, but not I-II, were at risk of gastric cancer after H. pylori eradication. Age, OLGA stages ≥ I, and OLGIM stages ≥ I were independent factors correlated to a persistent high-risk of gastric cancer. The data may be useful when scheduling surveillance endoscopy for subjects in each Correa's step (NCT04527055).CONCLUSIONThe patients in Correa's steps III-V, but not I-II, were at risk of gastric cancer after H. pylori eradication. Age, OLGA stages ≥ I, and OLGIM stages ≥ I were independent factors correlated to a persistent high-risk of gastric cancer. The data may be useful when scheduling surveillance endoscopy for subjects in each Correa's step (NCT04527055). |
Author | Yu, Yu-Ting Yang, Er-Hsiang Wu, Chung-Tai Yang, Hsiao-Bai Chen, Wei-Ying Cheng, Hsiu-Chi Yang, Yao-Jong Kuo, Hsin-Yu Sheu, Bor-Shyang Cheng, Wei-Chun Tsai, Yu-Ching Chang, Wei-Lun |
Author_xml | – sequence: 1 givenname: Hsiu-Chi orcidid: 0000-0003-0954-0647 surname: Cheng fullname: Cheng, Hsiu-Chi email: teishuki@mail.ncku.edu.tw organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 2 givenname: Yao-Jong orcidid: 0000-0002-2164-138X surname: Yang fullname: Yang, Yao-Jong organization: Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 3 givenname: Hsiao-Bai surname: Yang fullname: Yang, Hsiao-Bai organization: Department of Pathology, and Public Health, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 4 givenname: Yu-Ching surname: Tsai fullname: Tsai, Yu-Ching organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 5 givenname: Wei-Lun surname: Chang fullname: Chang, Wei-Lun organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 6 givenname: Chung-Tai surname: Wu fullname: Wu, Chung-Tai organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 7 givenname: Hsin-Yu orcidid: 0000-0002-6413-7669 surname: Kuo fullname: Kuo, Hsin-Yu organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 8 givenname: Yu-Ting orcidid: 0000-0002-9681-4564 surname: Yu fullname: Yu, Yu-Ting organization: Department of Pathology, and Public Health, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 9 givenname: Er-Hsiang surname: Yang fullname: Yang, Er-Hsiang organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 10 givenname: Wei-Chun surname: Cheng fullname: Cheng, Wei-Chun organization: Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan – sequence: 11 givenname: Wei-Ying orcidid: 0000-0001-5074-3097 surname: Chen fullname: Chen, Wei-Ying organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan – sequence: 12 givenname: Bor-Shyang surname: Sheu fullname: Sheu, Bor-Shyang organization: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36463082$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFu3CAQhlGVqtmkfYEeKm7txS5gA3bUS7RKm0iRemnPCMN4y9Y2LuCV9j3ywGWzSQ45JCfQ8H8_o3_mDJ1MfgKEPlJSUkLF12257UddMsJYSWlJSPMGrWgjRUEaRk_QirSsLYSoxSk6i3FLSC3aVrxDp1WuVVm0QndXOz8syfkJ-x6nP4DXPgTQnyM2OhptAccEc7zAl3jw06ZIEEYMk_XR-NkZHJewAzcMejKA9ZglOLdZLIOBgO0-zhl2GuvJ4o2OKWTk-Kb7bIWvSzzvBx8chqCtM_rQynv0ttdDhA8P5zn6_f3q1_q6uP3542Z9eVsYTmUqOO9q1lNgrAdoOs7qRtYguBCSNVQ3LbOyyrdadpUVomoJl4zrTtat5ZaI6hzdHH2t11s1BzfqsFdeO3Vf8GGjdEjODKAoo5RowRirmrqtha5NV3GQtGHcyN5mry9Hrzn4fwvEpEYXDRyCAb9ExWSOvJWU8iz99CBduhHs08ePU8mC5igwwccYoFfGpftkUtBuUJSowwKorTosgDosgKJU5QXIKHuGPrq_CH07QpDD3jkIKhoHeaDWBTApp-Fexi-e4WZwU57l8Bf2r8H_AWJf3EA |
CitedBy_id | crossref_primary_10_1016_j_jfma_2023_04_008 crossref_primary_10_3390_life15030406 crossref_primary_10_37349_edd_2024_00043 crossref_primary_10_46563_1560_9561_2023_26_1_67_74 crossref_primary_10_14309_ajg_0000000000003350 crossref_primary_10_1177_03936155231217268 crossref_primary_10_3390_nu17010142 crossref_primary_10_1016_j_ajpath_2023_10_007 crossref_primary_10_1111_hel_13033 |
Cites_doi | 10.1038/s41395-018-0353-8 10.1038/bjc.1998.475 10.1016/j.gie.2016.02.028 10.1136/gutjnl-2017-314600 10.1136/gutjnl-2015-309252 10.1159/000460245 10.1016/S0140-6736(14)61682-2 10.1055/a-0808-3186 10.1097/00000478-199610000-00001 10.5271/sjweh.3287 10.1136/gutjnl-2017-314498 10.1136/gutjnl-2018-318126 10.1016/j.dld.2008.02.030 10.1214/aos/1176344136 10.1055/a-0859-1883 10.1111/j.1751-2980.2011.00550.x 10.1111/hel.12385 10.1053/j.gastro.2009.07.060 10.1371/journal.pone.0219865 10.1111/apt.12291 10.1016/j.cgh.2013.09.064 10.1136/gutjnl-2012-302084 10.1002/ijc.28999 10.1053/j.gastro.2007.11.009 10.1016/S0002-9440(10)63511-0 10.1053/j.gastro.2019.12.003 10.1016/j.gie.2009.12.029 10.1371/journal.pone.0163700 10.1038/modpathol.3880198 10.1158/1055-9965.EPI-06-0758 10.1111/hel.12185 10.1037/1082-989X.4.2.139 10.1001/jama.291.2.187 10.1136/gutjnl-2019-318720 10.5946/ce.2019.072 10.1097/00001648-199901000-00008 10.1136/gutjnl-2020-322368 10.1007/s00428-021-03033-5 10.1111/hel.12368 |
ContentType | Journal Article |
Copyright | 2022 Copyright © 2022. Published by Elsevier B.V. |
Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier B.V. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/j.jfma.2022.11.008 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1876-0821 |
EndPage | 410 |
ExternalDocumentID | oai_doaj_org_article_12110a6222384946a4cb35e71825c7fd 36463082 10_1016_j_jfma_2022_11_008 S0929664622004302 |
Genre | Journal Article |
GroupedDBID | --- --K .1- .55 .FO .~1 0R~ 188 1B1 1P~ 1~. 1~5 2UF 2WC 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 8RM AABNK AAEDW AAIKJ AALRI AAQFI AAWTL AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABWVN ABXDB ACGFO ACRPL ACVFH ADCNI ADMUD ADNMO ADVLN AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AGYEJ AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ CS3 DU5 EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU GBLVA GROUPED_DOAJ GX1 HVGLF HZ~ IHE IPNFZ J1W M41 MO0 N9A O-L O9- OK1 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SSZ TR2 UZ5 X7M Z5R ZXP 0SF 6I. AACTN AAFTH AFCTW AHPSJ AINHJ CEFSP CNMHZ LCYCR NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c517t-55b42f1e22fee8b524874e65667281a892d7328147b3d663905725ab749d5d063 |
IEDL.DBID | .~1 |
ISSN | 0929-6646 |
IngestDate | Wed Aug 27 01:30:09 EDT 2025 Thu Jul 10 21:53:48 EDT 2025 Thu Jan 02 22:53:23 EST 2025 Tue Jul 01 03:18:45 EDT 2025 Thu Apr 24 22:56:38 EDT 2025 Fri Feb 23 02:37:27 EST 2024 Tue Aug 26 20:29:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | EGD CGI Atrophic gastritis CI ROC H. pylori precancerous Conditions IQR Stomach neoplasms SD OLGA OLGIM Helicobacter pylori |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2022. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c517t-55b42f1e22fee8b524874e65667281a892d7328147b3d663905725ab749d5d063 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-2164-138X 0000-0002-9681-4564 0000-0002-6413-7669 0000-0003-0954-0647 0000-0001-5074-3097 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0929664622004302 |
PMID | 36463082 |
PQID | 2746397115 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_12110a6222384946a4cb35e71825c7fd proquest_miscellaneous_2746397115 pubmed_primary_36463082 crossref_citationtrail_10_1016_j_jfma_2022_11_008 crossref_primary_10_1016_j_jfma_2022_11_008 elsevier_sciencedirect_doi_10_1016_j_jfma_2022_11_008 elsevier_clinicalkey_doi_10_1016_j_jfma_2022_11_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2023 2023-05-00 2023-May 20230501 2023-05-01 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: May 2023 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Journal of the Formosan Medical Association |
PublicationTitleAlternate | J Formos Med Assoc |
PublicationYear | 2023 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Amieva, El-Omar (bib5) 2008; 134 Gupta, Li, El Serag, Davitkov, Altayar, Sultan (bib14) 2020; 158 Wong, Lam, Wong, Chen, Zheng, Feng (bib31) 2004; 291 Goldstein (bib39) 2000; 13 (bib42) 2015; 385 den Hollander, Holster, den Hoed, Capelle, Tang, Anten (bib10) 2019; 68 (bib16) 2008 Rugge, Correa, Di Mario, El-Omar, Fiocca, Geboes (bib19) 2008; 40 Wu, Kuo, Wu, Chen, Wang, Lin (bib32) 2009; 137 Garwood F. Hou, Sheu, Liang, Hsieh, Lee, Chuang (bib27) 2012; 38 Kim, Liang, Bang, Hwang (bib11) 2016; 84 Rugge, Meggio, Pravadelli, Barbareschi, Fassan, Gentilini (bib38) 2019; 68 Quach, Hiyama (bib40) 2019; 52 Miehlke, Hackelsberger, Meining, Hatz, Lehn, Malfertheiner (bib4) 1998; 78 Capelle, de Vries, Haringsma, Ter Borg, de Vries, Bruno (bib20) 2010; 71 Cheng, Tsai, Yang, Yeh, Chang, Kuo (bib7) 2017; 22 Tsai, Hsiao, Yang, Cheng, Chang, Lu (bib6) 2013; 37 Liou, Malfertheiner, Lee, Sheu, Sugano, Cheng (bib15) 2020; 69 Lin (bib12) 2014; 12 Rugge, Genta, Fassan, Valentini, Coati, Guzzinati (bib9) 2018; 113 Malfertheiner, Megraud, O'Morain, Atherton, Axon, Bazzoli (bib22) 2012; 61 Greenland, Pearl, Robins (bib28) 1999; 10 Quach, Hiyama, Gotoda (bib35) 2020; 69 Plummer, Franceschi, Vignat, Forman, de Martel (bib2) 2015; 136 Akbari, Tabrizi, Kardeh, Lankarani (bib8) 2019; 14 Kang, Lee, Hwang, Lee, Kim, Kim (bib30) 2003; 153 Esposito, Pimentel-Nenes, Angeletti, Castro, Libânio, Galli (bib41) 2019; 51 Lee, Lin, Wu, Liu, Yen, Chiu (bib33) 2007; 16 Sheu, Wu, Chiu, Lo, Wu, Liou (bib23) 2017; 22 Nagin (bib24) 1999; 4 Schwarz (bib26) 1978; 6 Sugano, Tack, Kuipers, Graham, El-Omar, Miura (bib29) 2015; 64 Correa, Piazuelo (bib3) 2012; 13 Cheng, Wang, Chen, Chen, Chang, Sheu (bib34) 2015; 20 World Health Organization (bib1) Pimentel-Nunes, Libânio, Marcos-Pinto, Areia, Leja, Esposito (bib21) 2019; 51 Wada, Nakajima, Kushima, Takemura, Mori, Hasegawa (bib17) 2021; 479 Tahara, Shibata, Horiguchi, Kawamura, Okubo, Ishizuka (bib36) 2016; 11 Banks, Graham, Jansen, Gotoda, Coda, di Pietro (bib13) 2019; 68 Dixon, Genta, Yardley, Correa (bib18) 1996; 20 Majima, Handa, Naito, Dohi, Okayama, Yoshida (bib37) 2017; 95 Gupta (10.1016/j.jfma.2022.11.008_bib14) 2020; 158 Schwarz (10.1016/j.jfma.2022.11.008_bib26) 1978; 6 Quach (10.1016/j.jfma.2022.11.008_bib35) 2020; 69 Miehlke (10.1016/j.jfma.2022.11.008_bib4) 1998; 78 Capelle (10.1016/j.jfma.2022.11.008_bib20) 2010; 71 Lee (10.1016/j.jfma.2022.11.008_bib33) 2007; 16 Wong (10.1016/j.jfma.2022.11.008_bib31) 2004; 291 Sheu (10.1016/j.jfma.2022.11.008_bib23) 2017; 22 Pimentel-Nunes (10.1016/j.jfma.2022.11.008_bib21) 2019; 51 Kang (10.1016/j.jfma.2022.11.008_bib30) 2003; 153 Esposito (10.1016/j.jfma.2022.11.008_bib41) 2019; 51 den Hollander (10.1016/j.jfma.2022.11.008_bib10) 2019; 68 Rugge (10.1016/j.jfma.2022.11.008_bib19) 2008; 40 Greenland (10.1016/j.jfma.2022.11.008_bib28) 1999; 10 Cheng (10.1016/j.jfma.2022.11.008_bib34) 2015; 20 10.1016/j.jfma.2022.11.008_sref25 Wada (10.1016/j.jfma.2022.11.008_bib17) 2021; 479 Malfertheiner (10.1016/j.jfma.2022.11.008_bib22) 2012; 61 Amieva (10.1016/j.jfma.2022.11.008_bib5) 2008; 134 Quach (10.1016/j.jfma.2022.11.008_bib40) 2019; 52 Tsai (10.1016/j.jfma.2022.11.008_bib6) 2013; 37 Sugano (10.1016/j.jfma.2022.11.008_bib29) 2015; 64 Nagin (10.1016/j.jfma.2022.11.008_bib24) 1999; 4 Correa (10.1016/j.jfma.2022.11.008_bib3) 2012; 13 Rugge (10.1016/j.jfma.2022.11.008_bib9) 2018; 113 Plummer (10.1016/j.jfma.2022.11.008_bib2) 2015; 136 Lin (10.1016/j.jfma.2022.11.008_bib12) 2014; 12 (10.1016/j.jfma.2022.11.008_bib42) 2015; 385 Banks (10.1016/j.jfma.2022.11.008_bib13) 2019; 68 Goldstein (10.1016/j.jfma.2022.11.008_bib39) 2000; 13 Tahara (10.1016/j.jfma.2022.11.008_bib36) 2016; 11 (10.1016/j.jfma.2022.11.008_bib16) 2008 World Health Organization (10.1016/j.jfma.2022.11.008_bib1) Rugge (10.1016/j.jfma.2022.11.008_bib38) 2019; 68 Wu (10.1016/j.jfma.2022.11.008_bib32) 2009; 137 Cheng (10.1016/j.jfma.2022.11.008_bib7) 2017; 22 Liou (10.1016/j.jfma.2022.11.008_bib15) 2020; 69 Dixon (10.1016/j.jfma.2022.11.008_bib18) 1996; 20 Hou (10.1016/j.jfma.2022.11.008_bib27) 2012; 38 Akbari (10.1016/j.jfma.2022.11.008_bib8) 2019; 14 Majima (10.1016/j.jfma.2022.11.008_bib37) 2017; 95 Kim (10.1016/j.jfma.2022.11.008_bib11) 2016; 84 (10.1016/j.jfma.2022.11.008_bib25i) 1936; 28 |
References_xml | – volume: 113 start-page: 1621 year: 2018 end-page: 1628 ident: bib9 article-title: OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients publication-title: Am J Gastroenterol – volume: 13 start-page: 1072 year: 2000 end-page: 1079 ident: bib39 article-title: Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients publication-title: Mod Pathol – volume: 22 year: 2017 ident: bib7 article-title: The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of publication-title: Helicobacter – volume: 40 start-page: 650 year: 2008 end-page: 658 ident: bib19 article-title: OLGA staging for gastritis: a tutorial publication-title: Dig Liver Dis – volume: 137 start-page: 1641 year: 2009 end-page: 1648 ident: bib32 article-title: Early publication-title: Gastroenterology – volume: 68 start-page: 585 year: 2019 end-page: 593 ident: bib10 article-title: Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions publication-title: Gut – volume: 38 start-page: 3456 year: 2012 end-page: 3466 ident: bib27 article-title: Trajectories and predictors of return to work after traumatic limb injury-a 2-year follow-up study publication-title: Scand J Work Environ Health – volume: 4 start-page: 139 year: 1999 end-page: 157 ident: bib24 article-title: Analyzing developmental trajectories: a semi-parametric, group-based approach publication-title: Psychol Methods – volume: 20 start-page: 114 year: 2015 end-page: 124 ident: bib34 article-title: test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database publication-title: Helicobacter – volume: 13 start-page: 2 year: 2012 end-page: 9 ident: bib3 article-title: The gastric precancerous cascade publication-title: J Dig Dis – volume: 20 start-page: 1161 year: 1996 end-page: 1181 ident: bib18 article-title: Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994 publication-title: Am J Surg Pathol – volume: 64 start-page: 1353 year: 2015 end-page: 1367 ident: bib29 article-title: Kyoto global consensus report on publication-title: Gut – volume: 69 start-page: 2093 year: 2020 end-page: 2112 ident: bib15 article-title: Screening and eradication of publication-title: Gut – volume: 51 start-page: 365 year: 2019 end-page: 388 ident: bib21 article-title: Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European publication-title: Endoscopy – volume: 95 start-page: 194 year: 2017 end-page: 200 ident: bib37 article-title: Early-stage gastric cancer can be found in improved atrophic mucosa over time from successful publication-title: Digestion – volume: 69 start-page: 968 year: 2020 end-page: 969 ident: bib35 article-title: Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance? publication-title: Gut – volume: 84 start-page: 18 year: 2016 end-page: 28 ident: bib11 article-title: Screening and surveillance for gastric cancer in the United States: is it needed? publication-title: Gastrointest Endosc – volume: 291 start-page: 187 year: 2004 end-page: 194 ident: bib31 article-title: eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial publication-title: JAMA – volume: 6 start-page: 461 year: 1978 end-page: 464 ident: bib26 article-title: Estimating the dimension of a model publication-title: Ann Stat – volume: 51 start-page: 515 year: 2019 end-page: 521 ident: bib41 article-title: Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study publication-title: Endoscopy – ident: bib1 article-title: Cancer – volume: 78 start-page: 263 year: 1998 end-page: 266 ident: bib4 article-title: Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori publication-title: Br J Cancer – volume: 22 year: 2017 ident: bib23 article-title: Consensus on the clinical management, screening-to-treat, and surveillance of publication-title: Helicobacter – volume: 10 start-page: 37 year: 1999 end-page: 48 ident: bib28 article-title: Causal diagrams for epidemiologic research publication-title: Epidemiology – volume: 158 start-page: 693 year: 2020 end-page: 702 ident: bib14 article-title: AGA clinical practice guidelines on management of gastric intestinal metaplasia publication-title: Gastroenterology – volume: 153 start-page: 1551 year: 2003 end-page: 1556 ident: bib30 article-title: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation publication-title: Am J Pathol – volume: 71 start-page: 1150 year: 2010 end-page: 1158 ident: bib20 article-title: The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis publication-title: Gastrointest Endosc – volume: 16 start-page: 875 year: 2007 end-page: 885 ident: bib33 article-title: Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer publication-title: Cancer Epidemiol Biomarkers Prev – volume: 11 year: 2016 ident: bib36 article-title: A possible link between gastric mucosal atrophy and gastric cancer after publication-title: PLoS One – volume: 61 start-page: 646 year: 2012 end-page: 664 ident: bib22 article-title: Management of publication-title: Gut – volume: 52 start-page: 321 year: 2019 end-page: 327 ident: bib40 article-title: Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice publication-title: Clin Endosc – volume: 12 start-page: 135 year: 2014 end-page: 138 ident: bib12 article-title: Screening of gastric cancer: who, when, and how publication-title: Clin Gastroenterol Hepatol – volume: 37 start-page: 969 year: 2013 end-page: 978 ident: bib6 article-title: The corpus-predominant gastritis index may serve as an early marker of publication-title: Aliment Pharmacol Ther – volume: 68 start-page: 1545 year: 2019 end-page: 1575 ident: bib13 article-title: British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma publication-title: Gut – volume: 136 start-page: 487 year: 2015 end-page: 490 ident: bib2 article-title: Global burden of gastric cancer attributable to Helicobacter pylori publication-title: Int J Cancer – volume: 14 year: 2019 ident: bib8 article-title: Gastric cancer in patients with gastric atrophy and intestinal metaplasia: a systematic review and meta-analysis publication-title: PLoS One – volume: 479 start-page: 169 year: 2021 end-page: 178 ident: bib17 article-title: Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients publication-title: Virchows Arch – volume: 68 start-page: 11 year: 2019 end-page: 17 ident: bib38 article-title: Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients publication-title: Gut – start-page: 135 year: 2008 end-page: 231 ident: bib16 article-title: The nonneoplastic stomach publication-title: Gastrointestinal pathology: an atlas and text – volume: 134 start-page: 306 year: 2008 end-page: 323 ident: bib5 article-title: Host-bacterial interactions in publication-title: Gastroenterology – reference: Garwood F. – volume: 385 start-page: 117 year: 2015 end-page: 171 ident: bib42 article-title: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013 publication-title: Lancet – volume: 113 start-page: 1621 year: 2018 ident: 10.1016/j.jfma.2022.11.008_bib9 article-title: OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients publication-title: Am J Gastroenterol doi: 10.1038/s41395-018-0353-8 – volume: 28 start-page: 437 year: 1936 ident: 10.1016/j.jfma.2022.11.008_bib25i publication-title: Fiducial limits for the Poisson distribution Biometrika – volume: 78 start-page: 263 year: 1998 ident: 10.1016/j.jfma.2022.11.008_bib4 article-title: Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori publication-title: Br J Cancer doi: 10.1038/bjc.1998.475 – volume: 84 start-page: 18 year: 2016 ident: 10.1016/j.jfma.2022.11.008_bib11 article-title: Screening and surveillance for gastric cancer in the United States: is it needed? publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2016.02.028 – volume: 68 start-page: 11 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib38 article-title: Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients publication-title: Gut doi: 10.1136/gutjnl-2017-314600 – volume: 64 start-page: 1353 year: 2015 ident: 10.1016/j.jfma.2022.11.008_bib29 article-title: Kyoto global consensus report on Helicobacter pylori gastritis publication-title: Gut doi: 10.1136/gutjnl-2015-309252 – volume: 95 start-page: 194 year: 2017 ident: 10.1016/j.jfma.2022.11.008_bib37 article-title: Early-stage gastric cancer can be found in improved atrophic mucosa over time from successful Helicobacter pylori eradication publication-title: Digestion doi: 10.1159/000460245 – volume: 385 start-page: 117 year: 2015 ident: 10.1016/j.jfma.2022.11.008_bib42 article-title: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013 publication-title: Lancet doi: 10.1016/S0140-6736(14)61682-2 – volume: 51 start-page: 515 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib41 article-title: Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study publication-title: Endoscopy doi: 10.1055/a-0808-3186 – volume: 20 start-page: 1161 year: 1996 ident: 10.1016/j.jfma.2022.11.008_bib18 article-title: Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994 publication-title: Am J Surg Pathol doi: 10.1097/00000478-199610000-00001 – volume: 38 start-page: 3456 year: 2012 ident: 10.1016/j.jfma.2022.11.008_bib27 article-title: Trajectories and predictors of return to work after traumatic limb injury-a 2-year follow-up study publication-title: Scand J Work Environ Health doi: 10.5271/sjweh.3287 – volume: 68 start-page: 585 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib10 article-title: Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions publication-title: Gut doi: 10.1136/gutjnl-2017-314498 – volume: 68 start-page: 1545 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib13 article-title: British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma publication-title: Gut doi: 10.1136/gutjnl-2018-318126 – volume: 40 start-page: 650 year: 2008 ident: 10.1016/j.jfma.2022.11.008_bib19 article-title: OLGA staging for gastritis: a tutorial publication-title: Dig Liver Dis doi: 10.1016/j.dld.2008.02.030 – volume: 6 start-page: 461 year: 1978 ident: 10.1016/j.jfma.2022.11.008_bib26 article-title: Estimating the dimension of a model publication-title: Ann Stat doi: 10.1214/aos/1176344136 – volume: 51 start-page: 365 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib21 publication-title: Endoscopy doi: 10.1055/a-0859-1883 – volume: 13 start-page: 2 year: 2012 ident: 10.1016/j.jfma.2022.11.008_bib3 article-title: The gastric precancerous cascade publication-title: J Dig Dis doi: 10.1111/j.1751-2980.2011.00550.x – volume: 22 year: 2017 ident: 10.1016/j.jfma.2022.11.008_bib7 article-title: The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia publication-title: Helicobacter doi: 10.1111/hel.12385 – volume: 137 start-page: 1641 year: 2009 ident: 10.1016/j.jfma.2022.11.008_bib32 article-title: Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.07.060 – volume: 14 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib8 article-title: Gastric cancer in patients with gastric atrophy and intestinal metaplasia: a systematic review and meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0219865 – volume: 37 start-page: 969 year: 2013 ident: 10.1016/j.jfma.2022.11.008_bib6 article-title: The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12291 – volume: 12 start-page: 135 year: 2014 ident: 10.1016/j.jfma.2022.11.008_bib12 article-title: Screening of gastric cancer: who, when, and how publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.09.064 – volume: 61 start-page: 646 year: 2012 ident: 10.1016/j.jfma.2022.11.008_bib22 article-title: Management of Helicobacter pylori infection--the maastricht IV/florence consensus report publication-title: Gut doi: 10.1136/gutjnl-2012-302084 – volume: 136 start-page: 487 year: 2015 ident: 10.1016/j.jfma.2022.11.008_bib2 article-title: Global burden of gastric cancer attributable to Helicobacter pylori publication-title: Int J Cancer doi: 10.1002/ijc.28999 – volume: 134 start-page: 306 year: 2008 ident: 10.1016/j.jfma.2022.11.008_bib5 article-title: Host-bacterial interactions in Helicobacter pylori infection publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.11.009 – volume: 153 start-page: 1551 year: 2003 ident: 10.1016/j.jfma.2022.11.008_bib30 article-title: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63511-0 – volume: 158 start-page: 693 year: 2020 ident: 10.1016/j.jfma.2022.11.008_bib14 article-title: AGA clinical practice guidelines on management of gastric intestinal metaplasia publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.12.003 – ident: 10.1016/j.jfma.2022.11.008_bib1 – volume: 71 start-page: 1150 year: 2010 ident: 10.1016/j.jfma.2022.11.008_bib20 article-title: The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2009.12.029 – volume: 11 year: 2016 ident: 10.1016/j.jfma.2022.11.008_bib36 article-title: A possible link between gastric mucosal atrophy and gastric cancer after Helicobacter pylori eradication publication-title: PLoS One doi: 10.1371/journal.pone.0163700 – volume: 13 start-page: 1072 year: 2000 ident: 10.1016/j.jfma.2022.11.008_bib39 article-title: Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients publication-title: Mod Pathol doi: 10.1038/modpathol.3880198 – start-page: 135 year: 2008 ident: 10.1016/j.jfma.2022.11.008_bib16 article-title: The nonneoplastic stomach – ident: 10.1016/j.jfma.2022.11.008_sref25 – volume: 16 start-page: 875 year: 2007 ident: 10.1016/j.jfma.2022.11.008_bib33 article-title: Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0758 – volume: 20 start-page: 114 year: 2015 ident: 10.1016/j.jfma.2022.11.008_bib34 article-title: Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database publication-title: Helicobacter doi: 10.1111/hel.12185 – volume: 4 start-page: 139 year: 1999 ident: 10.1016/j.jfma.2022.11.008_bib24 article-title: Analyzing developmental trajectories: a semi-parametric, group-based approach publication-title: Psychol Methods doi: 10.1037/1082-989X.4.2.139 – volume: 291 start-page: 187 year: 2004 ident: 10.1016/j.jfma.2022.11.008_bib31 article-title: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.291.2.187 – volume: 69 start-page: 968 year: 2020 ident: 10.1016/j.jfma.2022.11.008_bib35 article-title: Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance? publication-title: Gut doi: 10.1136/gutjnl-2019-318720 – volume: 52 start-page: 321 year: 2019 ident: 10.1016/j.jfma.2022.11.008_bib40 article-title: Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice publication-title: Clin Endosc doi: 10.5946/ce.2019.072 – volume: 10 start-page: 37 year: 1999 ident: 10.1016/j.jfma.2022.11.008_bib28 article-title: Causal diagrams for epidemiologic research publication-title: Epidemiology doi: 10.1097/00001648-199901000-00008 – volume: 69 start-page: 2093 year: 2020 ident: 10.1016/j.jfma.2022.11.008_bib15 article-title: Screening and eradication of Helicobacter pylori for gastric cancer prevention-the Taipei global consensus publication-title: Gut doi: 10.1136/gutjnl-2020-322368 – volume: 479 start-page: 169 year: 2021 ident: 10.1016/j.jfma.2022.11.008_bib17 article-title: Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients publication-title: Virchows Arch doi: 10.1007/s00428-021-03033-5 – volume: 22 year: 2017 ident: 10.1016/j.jfma.2022.11.008_bib23 article-title: Consensus on the clinical management, screening-to-treat, and surveillance of H. pylori infection to improve gastric cancer control on a nationwide scale publication-title: Helicobacter doi: 10.1111/hel.12368 |
SSID | ssj0046996 |
Score | 2.3615057 |
Snippet | This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and exploring the... Background: This study is aimed toward investigating the evolution of each Correa's step after Helicobacter pylori eradication in a long-term follow-up and... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 400 |
SubjectTerms | Atrophic gastritis Dyspepsia Endoscopy, Gastrointestinal Gastric Mucosa Gastritis - epidemiology Helicobacter Infections - complications Helicobacter Infections - drug therapy Helicobacter Infections - epidemiology Helicobacter pylori Humans Middle Aged precancerous Conditions Risk Factors Stomach Neoplasms Stomach Ulcer |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NaxsxEBUlh9BLadIvN22ZQqGHotSrlXatYxoSTCE9NZCb0NcGB7NrvHag_yM_ODNarUkPTS692itb2pmdebMavcfYF19jDdDUkQfdlFxqr7nGWMxjLGIogi9cUm-4-FXNL-XPK3X1QOqLesIGeuDhxn0nCrKprSiNzaSWlZXelSpiSBXK102g6Is5byymhhiMNV9S5ppqau6oZJWPywydXTdNYhwS4pj4O0lY8kFKSsz9f2WmfyHPlIHOX7IXGTrCyTDlA_Ystods_yJvjr9id2e32Y-gawCBHZyS9Ib92oO3PfXBA5oU1w8nsOzaa05RGWIbOjqasvDQb9e3kVSI0BEgqRBB27V8u_RxDeFPv8LBCwu2DXBtSe_Dw_BdEhqH-TGsqPxfQFzbkN8FvmaX52e_T-c8iy5wr4p6w5VyUjRFFKKJceaUwIpGRkJ9tZgVdqZFIH6fQtauDAhXNAI-oayrpQ4qIOB5w_ZwbvEdA6wVbbDTxsngpY7SCodgRZd01tVjWThhxXjfjc-M5CSMsTRj69mNIVsZshWWKgZtNWHfdmNWAx_Ho1f_IHPuriQu7fQBepjJHmae8rAJK0dnMONxVQyw-EOLR_9a7UZlMDOAlCfHfR79zeCTTts3to3dtjeilrQLixB-wt4OjrhbWIk-TsRD7__Hgo_Yc5xQbuv8wPY26238iNBr4z6lp-weQisndQ priority: 102 providerName: Directory of Open Access Journals |
Title | Evolution of the Correa's cascade steps: A long-term endoscopic surveillance among non-ulcer dyspepsia and gastric ulcer after H. pylori eradication |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0929664622004302 https://dx.doi.org/10.1016/j.jfma.2022.11.008 https://www.ncbi.nlm.nih.gov/pubmed/36463082 https://www.proquest.com/docview/2746397115 https://doaj.org/article/12110a6222384946a4cb35e71825c7fd |
Volume | 122 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbLHkovpe-mj2UKhR6Kk1iW7Oi4DbuEwvbSLuxNyJIcvAQ72MlCL_sr9gd3RpZD99At9BhHih3NeOYbaeYbxj7ZAmOAqvCJU1WWCGVVotAWJ96n3qXOpmXo3nDxPV9dim9X8uqILcdaGEqrjLZ_sOnBWscrs7ias21dz37M0bPnucg5D8RVZIeFKEjLp7eHNA-M_kKPLhqc0OhYODPkeF1XgXuI8ykxeVKLyT-cU-Dwv-ej_oZBgy86f8qeRBAJp8NzPmNHvnnOHl3EY_IX7O7sJmoUtBUgxIMlNeEwn3uwpqeMeEDh4krAKWzaZp2QfQbfuJaKVGoL_b678dSPCJcDQj8iaNom2W-s78D96rc4uTZgGgdrQ50_LAzfhZbjsJrCljYCavCdcXFX8CW7PD_7uVwlsf1CYmVa7BIpS8Gr1HNeeb8oJcfYRnjCfwVfpGahuCOmn1QUZeYQuCiEflyashDKSYfQ5xU7xmfzbxhg1GicmVelcFYoLwwvEbaojKpeLQaIE5aO665t5CanFhkbPSahXWuSlSZZYdCiUVYT9uUwZzswczw4-iuJ8zCSWLXDhbZb66hWmuju5iYnyLQQSuRG2DKTHt03l7ao3IRlozLosXAVTS3-UP3greVh1j3V_ue8j6O-aXzn6SDHNL7d95oXgs5jEcxP2OtBEQ9_LEMdJwqit_9513fsMX6KOZ3v2fGu2_sPiLt25Ul4sU7CrsVvS4MqNA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZWiwRcEG_K00hIHJDbxrGT-rhUuyqw3Qu70t4sx3aqrKqkatqVuPAr-MHMOE7EHlgkrondpJ7xzDfxzHyEfLA5xABl7plTZcqEsoopsMXM-8S7xNmkCOwNy7NscSG-XsrLAzLva2EwrTLa_s6mB2sdr0ziak42VTX5PgXPnmUi4zw0rgI7fEfA9sXdOf455HlA-BdIunA0w-GxcqZL8roqQ_MhzsfYyhM5Jv_wTqGJ_w0n9TcQGpzRyUPyIKJIetS96CNy4OvH5O4ynpM_Ib-Or6NK0aakgPHoHFk4zMeWWtNiSjwF6cJS0CO6buoVQwNNfe0arFKpLG3322uPhESwHjQQEtG6qdl-bf2Wuh_tBiZXhpra0ZVB6g9Lu3uBc5wuxnSDXwIq6rfGxc-CT8nFyfH5fMEi_wKzMsl3TMpC8DLxnJfezwrJIbgRHgFgzmeJmSnusNVPIvIidYBcFGA_Lk2RC-WkA-zzjBzCu_kXhELYaJyZloVwVigvDC8At6gUy14tRIgjkvTrrm1sTo4cGWvdZ6FdaZSVRllB1KJBViPyaZiz6Vpz3Dr6M4pzGIlttcOFZrvSUa809rubmgwx00wokRlhi1R68N9c2rx0I5L2yqD7ylWwtfBD1a2PlsOsG7r9z3nve33TsOnxJMfUvtm3mucCD2QBzY_I804Rhz-Wgo5jD6KX__nUd-Te4nx5qk-_nH17Re7DnZjg-Zoc7rZ7_wZA2K54GzbZby4aLFo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evolution+of+the+Correa%27s+cascade+steps%3A+A+long-term+endoscopic+surveillance+among+non-ulcer+dyspepsia+and+gastric+ulcer+after+H.+pylori+eradication&rft.jtitle=Journal+of+the+Formosan+Medical+Association&rft.au=Cheng%2C+Hsiu-Chi&rft.au=Yang%2C+Yao-Jong&rft.au=Yang%2C+Hsiao-Bai&rft.au=Tsai%2C+Yu-Ching&rft.date=2023-05-01&rft.pub=Elsevier+B.V&rft.issn=0929-6646&rft.eissn=1876-0821&rft.volume=122&rft.issue=5&rft.spage=400&rft.epage=410&rft_id=info:doi/10.1016%2Fj.jfma.2022.11.008&rft.externalDocID=S0929664622004302 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-6646&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-6646&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-6646&client=summon |